.youtube.com/watch?v=Lp2y64IPeVw
PSSD Interview with Anna from Croatia
Professor David Healy is a world-renowned psychiatrist, scientist, author, and a leading psycho-pharmacologist who is studying the condition called Post-SRRI Sexual Dysfunction (PSSD), an incurable, permanent illness that can occur after taking SSRIs or other modern antidepressant drugs, which does not go away after stopping the medication. PSSD sufferers say life feels pointless and that they no longer feel sexual or romantic feelings and so cannot fall in love. Many children and young adolescents who are given these medications who then go on to develop PSSD say they have no idea what sexual or romantic feelings are like.
Professor Healy believes the condition might more common than previously thought because it unreported as doctors usually dismiss it when their patients say their sex drive has not been the same after taking antidepressant drugs. Because of the nature of the condition patients feel too ashamed to mention it to anyone else. Many sufferers are lonely because their lack of sexual feelings and romantic passion makes relationships difficult.
A number of years ago the medical journalist, Robert Whitaker, wrote an article about it but no newspaper, magazine, or online media outlet would publish it. When the Oliver James, the left-leaning British psychiatrist who often writes for the MSM, was asked about it he said it would be difficult to publish. Apparently, newspapers rely too much on drug-company advertising and don't want to upset their customers.
Professor Healy is trying to raise money for a $100,000 prize for anyone who can develop a cure for this dreadful condition. If you wish to donate, there's the link below. Please re-blog this post.
Reprinted with permission from Rxisk
David Healy
This prize is part of a two-pronged attack on the unwillingness of the medical and regulatory establishments to listen to people with adverse events in general -- not just the sexual dysfunctions mentioned here. The second front in the attack will be unveiled in a few weeks' time.
The problem
The idea for a RxISK Prize began with our involvement with sufferers from Post-SSRI Sexual Dysfunction (PSSD) some years ago, and soon after people with comparable problems following Accutane and Finasteride. The motivation and endurance of those affected has been inspiring.
A complete and permanent wipe-out of your ability to make love is among the most debilitating side effects of a drug imaginable. In the case of all these drugs when it happens it affects men and women, young and old, can appear after a few days on the drug or only after treatment stops. It can last for decades, perhaps longer. It leads to suicides, the break-up of relationships and job losses. There is no upside to it.
PSSD shares many common features and looks like it is closely related to Post-Finasteride Syndrome (PFS), and Post-Retinoid Sexual Dysfunction (PRSD) triggered primarily by isotretinoin (Accutane). Isotretinoin is both a serotonin-reuptake inhibitor and a 5-alpha reductase inhibitor (5ARI), so it could give rise to PSSD or PFS, or all three conditions may have something else in common.
We have recently submitted a paper for review describing 300 cases of PSSD, PFS and PRSD, and we are aware of many more cases and comparable phenomena happening on some other drugs. There may be tens of thousands affected as some evidence suggests that less than half of those who have been on SSRIs for months will regain full and normal function.
There are communities online and linked to universities researching these conditions as vigorously as the AIDS community once got involved in the search of a cure for AIDS. The most successful of these so far have been linked to PFS, with sufferers having created a Foundation to promote research on this condition. The research done by these groups have followed up all of the obvious treatment leads but nothing so far has worked.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
